Search research articles
Contact Us
Filters
Showing results (71-80 of 190) with videos related to
Page
of 19
Sort By:
Journal of Medical Economics
|
August 14, 2012
Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States
Roman Casciano, Maruit Chulikavit, Allison Perrin, et al.
Health Economics
|
June 26, 2019
Do cancer treatments have option value? Real-world evidence from metastatic melanoma
Meng Li, Anirban Basu, Caroline S Bennette, et al.
Molecular Oncology
|
March 21, 2012
Paying for personalized care: cancer biomarkers and comparative effectiveness
Rahber Thariani, David L Veenstra, Josh J Carlson, et al.
Value in Health Regional Issues
|
February 22, 2023
Estimating the Potential Economic Impact of Tissue Valve Replacement for Heart Valve Disease in China: Patient-Level and Population-Level Cost-Benefit Simulation Analyses
Bruce Wang, Elizabeth Wu, Dirk Rassloff, et al.
Applied Health Economics and Health Policy
|
February 5, 2024
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations
Bethany Shinkins, A Joy Allen, James Karichu, et al.
Journal of Medical Economics
|
July 12, 2011
Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score
Sean D Sullivan, Louis P Garrison, Harald Rinde, et al.
Frontiers in Pharmacology
|
April 25, 2022
Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
András Incze, Zoltán Kaló, Jaime Espín, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
December 27, 2016
Cost-effectiveness analysis of the orbital atherectomy system: Two-year follow-up
Louis P Garrison, Marita R Zimmermann, Christopher H Young, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 1, 2025
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases
Walter Toro, Min Yang, Anish Patel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 25, 2007
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report
Louis P Garrison, Peter J Neumann, Pennifer Erickson, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 190) with videos related to
Sort By:
Page
of 19
Journal of Medical Economics
|
August 14, 2012
Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States
Roman Casciano, Maruit Chulikavit, Allison Perrin, et al.
Health Economics
|
June 26, 2019
Do cancer treatments have option value? Real-world evidence from metastatic melanoma
Meng Li, Anirban Basu, Caroline S Bennette, et al.
Molecular Oncology
|
March 21, 2012
Paying for personalized care: cancer biomarkers and comparative effectiveness
Rahber Thariani, David L Veenstra, Josh J Carlson, et al.
Value in Health Regional Issues
|
February 22, 2023
Estimating the Potential Economic Impact of Tissue Valve Replacement for Heart Valve Disease in China: Patient-Level and Population-Level Cost-Benefit Simulation Analyses
Bruce Wang, Elizabeth Wu, Dirk Rassloff, et al.
Applied Health Economics and Health Policy
|
February 5, 2024
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations
Bethany Shinkins, A Joy Allen, James Karichu, et al.
Journal of Medical Economics
|
July 12, 2011
Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score
Sean D Sullivan, Louis P Garrison, Harald Rinde, et al.
Frontiers in Pharmacology
|
April 25, 2022
Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
András Incze, Zoltán Kaló, Jaime Espín, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
December 27, 2016
Cost-effectiveness analysis of the orbital atherectomy system: Two-year follow-up
Louis P Garrison, Marita R Zimmermann, Christopher H Young, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 1, 2025
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases
Walter Toro, Min Yang, Anish Patel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 25, 2007
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report
Louis P Garrison, Peter J Neumann, Pennifer Erickson, et al.
Page
of 19